Dual inhibition of the PI3K/AKT/mTOR pathway suppresses the growth of leiomyosarcomas but leads to ERK activation through mTORC2: biological and clinical implications

Nom du journal : Oncotarget

Année : 2017

Volume : 8

Page de départ : 7878

Page de fin : 7890

Auteurs: Fourneaux B, Chaire V, Lucchesi C, Karanian M, Pineau R, Laroche-Clary A, Italiano A, Fourneaux B,